CORZ
Core Scientific, Inc
Core Scientific, Inc historical holders
total: 2
Oaktree Capital Management Core Scientific, Inc transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 2
- Held since:
- 2025 Q3
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q1
Howard Marks has been an institutional investor in Core Scientific, Inc (CORZ) since 2025 Q3. According to 2026 Q1 report, Howard Marks holds 9,350,708 shares with a market value of roughly $139.89M representing 2.37% of their equity portfolio. The fund/company first acquired CORZ in 2025 Q3, initially purchasing about 6.40M shares. Since the initial investment, Oaktree Capital Management has made 2 more transactions in this position.
Does Howard Marks still hold CORZ?
Yes, Howard Marks continues to hold Core Scientific, Inc (CORZ). According to their 2026 Q1 report, they maintain a position of 9,350,708 shares valued at approximately $139.89M, representing 2.37% of their equity portfolio.
When did Howard Marks first invest in CORZ?
Howard Marks first invested in Core Scientific, Inc (CORZ) in 2025 Q3 at the reported quarter-end price of $17.94 per share, acquiring 6,400,708 shares in their initial purchase.
What is Howard Marks's average cost basis for CORZ?
Based on historical transaction data, Howard Marks's estimated cost basis for Core Scientific, Inc (CORZ) is approximately $16.92 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $16.92
CORZ transactions history by Oaktree Capital Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.37%
|
9,350,708
|
$14.96
|
$139,886,591
|
+11.98% (+1,000,000)
|
+0.25%
|
|
2025 Q4
|
1.97%
|
8,350,708
|
$14.56
|
$121,586,308
|
+30.47% (+1,950,000)
|
+0.46%
|
|
2025 Q3
|
1.91%
|
6,400,708
|
$17.94
|
$114,828,701
|
new
|
+1.91%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.